BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22662254)

  • 21. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
    Nakano S; Inada Y; Masuzaki H; Tanaka T; Yasue S; Ishii T; Arai N; Ebihara K; Hosoda K; Maruyama K; Yamazaki Y; Shibata N; Nakao K
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress.
    Li Y; Bevilacqua E; Chiribau CB; Majumder M; Wang C; Croniger CM; Snider MD; Johnson PF; Hatzoglou M
    J Biol Chem; 2008 Aug; 283(33):22443-56. PubMed ID: 18550528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
    Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
    Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
    Tagawa N; Kubota S; Kato I; Kobayashi Y
    J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.
    Wamil M; Battle JH; Turban S; Kipari T; Seguret D; de Sousa Peixoto R; Nelson YB; Nowakowska D; Ferenbach D; Ramage L; Chapman KE; Hughes J; Dunbar DR; Seckl JR; Morton NM
    Diabetes; 2011 Apr; 60(4):1158-67. PubMed ID: 21350084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.
    Man TY; Michailidou Z; Gokcel A; Ramage L; Chapman KE; Kenyon CJ; Seckl JR; Morton NM
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1076-84. PubMed ID: 21406612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBPbeta.
    Carmona MC; Hondares E; Rodríguez de la Concepción ML; Rodríguez-Sureda V; Peinado-Onsurbe J; Poli V; Iglesias R; Villarroya F; Giralt M
    Biochem J; 2005 Jul; 389(Pt 1):47-56. PubMed ID: 15762841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
    Liu J; Wang L; Zhang A; Di W; Zhang X; Wu L; Yu J; Zha J; Lv S; Cheng P; Hu M; Li Y; Qi H; Ding G; Zhong Y
    Endocr J; 2011; 58(3):199-209. PubMed ID: 21325744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
    Bae EJ; Kim SG
    Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCAAT/enhancer-binding protein beta isoforms and the regulation of alpha-smooth muscle actin gene expression by IL-1 beta.
    Hu B; Wu Z; Jin H; Hashimoto N; Liu T; Phan SH
    J Immunol; 2004 Oct; 173(7):4661-8. PubMed ID: 15383601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute anti-obesity effects of intracerebroventricular 11β-HSD1 inhibitor administration in diet-induced obese mice.
    Seo M; Islam SA; Moon SS
    J Neuroendocrinol; 2018 Mar; 30(3):e12580. PubMed ID: 29418022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
    De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
    Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.
    Lee JH; Gao Z; Ye J
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1035-41. PubMed ID: 23512810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
    Zhang R; Kan JB; Lu S; Tong P; Yang J; Xi L; Liang X; Su D; Li D; Liu Y
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue.
    Veyrat-Durebex C; Deblon N; Caillon A; Andrew R; Altirriba J; Odermatt A; Rohner-Jeanrenaud F
    PLoS One; 2012; 7(3):e34002. PubMed ID: 22479501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 11β-HSD1 modulates LPS-induced innate immune responses in adipocytes by altering expression of PTEN.
    Lai W; Tian X; Xiang Q; Chu K; Wei Y; Deng J; Zhang S; Brown J; Hong G
    Mol Endocrinol; 2015 Apr; 29(4):558-70. PubMed ID: 25734515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
    Yang Z; Guo C; Zhu P; Li W; Myatt L; Sun K
    J Endocrinol; 2007 Nov; 195(2):241-53. PubMed ID: 17951535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.